Month: March 2020

von Willebrand\’s Disorder Info Day 2020 – Postponed

Our von Willebrand\’s Disorder Information Day 2020 which was scheduled for April 18th has unfortunately been postponed until further notice. The conference will be re-scheduled for later in the year and as soon as we have new dates, we will let you know. Apologies for any inconvenience caused.

Covid-19: Contingency Plan for Dental and Orthodontic Services

The HSE has published a Contingency Plan for Covid-19 for Dental and Orthodontic services – you can read it here. At present, only serious emergency dental treatment will be available. More specific information relating to Dental services at the National Coagulation Centre will be posted here early next week, when available.

Notice to patients registered with the National Coagulation Centre – March 12

This notice applies to you if you attend the NCC outpatient clinic, dental clinic, H&H assessment unit (HHAU), Warfarin or DOAC clinics The NCC clinical team have been monitoring the evolving situation regarding the novel Coronavirus and are following the guidance of the HSE and the Health Protection and Surveillance Centre. If you feel unwell …

Notice to patients registered with the National Coagulation Centre – March 12 Read More »

Young Adult Conference 2020 – Postponed

The Young Adult Conference 2020 which was scheduled to take place over the weekend of April 24 to 26, has been postponed until further notice. The conference will be re-scheduled for later in the year and as soon as we have new dates, we will let you know. Apologies for any inconvenience caused.

Notice to patients registered with the National Coagulation Centre (NCC)

This notice applies to you if you attend the NCC outpatient clinic, dental clinic, H&H assessment unit, Warfarin or DOAC clinics The NCC clinical team have been monitoring the evolving situation regarding the novel Coronavirus and are following the guidance of the HSE and the Health Protection and Surveillance Centre. If you feel unwell with …

Notice to patients registered with the National Coagulation Centre (NCC) Read More »

First person with haemophilia in Ireland treated with gene therapy

The Irish Haemophilia Society has today announced that gene therapy has been used for the first time to treat a person with haemophilia in Ireland. The recipient has received gene therapy as part of a Phase 3 clinical trial. The therapy uses an adeno-associated viral vector to deliver the Factor IX gene therapy intravenously to …

First person with haemophilia in Ireland treated with gene therapy Read More »